The World Bank has just published a massive new dataset – HEFPI – which documents disparities in health intervention coverage and health outcomes, and the incidence of catastrophic and impoverishing out-of-pocket medical expenses worldwide:
The HEFPI dataset contains 12,856 datapoints at the population level across 194 countries, of which 8,550 are available at the (wealth) quintile level too.
HEFPI spans the period 1982-2017, with 11,079 datapoints since 2000.
It contains 51 indicators in total, of which five cover financial protection, 18 medical intervention coverage, and 28 health outcomes.
Indicators were selected that are commonly used in international goals such as the Millennium Development Goals, the Sustainable Development Goals, Universal Health Coverage, the Non-Communicable Disease targets, etc.
The data come from over 1,600 household surveys. Wherever possible, HEFPI datapoints were computed from microdata to ensure consistency across countries and years – an advantage over data from sources like Multiple Indicator Cluster Survey (MICS) and Demographic and Health Survey (DHS) reports and the DHS StatCompiler tool.
There’s a data portal where you can explore data availability, and construct and save customized visualizations of the data.
Prof. dr. Stephen T. Chambers and Prof. dr. Jean W. Pape will be giving talks on “Migratory Health” and “TB & Healthcare in Vulnerable Populations”. Prof. Chambers is the Clinical Director of the Department of Infectious Diseases at Christchurch Hospital, New Zealand, and has published over 250 peer reviewed papers in medical journals among which are the BMJ, JAMA and the Lancet. Prof. Pape is Founder and Director of the GHESKIO Centers (Haitian Group for the Study of Kaposi’s Sarcoma and Opportunistic Infections). He has received numerous international awards for his work. In April 2002, French President Jacques Chirac awarded Prof. Pape the Legion of Honor Award for his “contribution to the improvement of the health of the Haitian people and that of people in the world, Dr. Pape was elected to the United States National Academy of Sciences Institute of Medicine in June 2003 and in 2010 received the 2010 Christophe Mérieux Prize.
Further information on the speakers and their talks can be found here.
Epke Le Rutte will be giving a talk “The impact of interventions on future incidence using visceral leishmaniasis transmission models” at the workshop Leishmaniasis Modelling & Economics: Towards a Future Research Agenda.
The workshop is in York and runs from the 16th to the 17th of October.
WorldLeish | 16 – 20 May 2017 | Toledo, Spain | 1500 participants | 6th World Congress on Leishmaniasis, organized once every 4 years
Erasmus MC was represented by Epke Le Rutte and Sake de Vlas from the Department of Public Health, who were invited speaker and co-chair respectively of the session “quantitative studies of leishmaniasis transmission and control” in which they highlighted the key policy relevant outcomes of their most recent modeling work on visceral leishmaniasis. In a different session, Epke also presented the work performed at the Department of Public Health at Erasmus MC in collaboration with the faculty of Veterinary Medicine at Utrecht University on the awareness and implementation of control measures by veterinarians against the spread of zoonotic visceral leishmaniasis in Spain and France.
Natalie Vinkeles Melchers (Erasmus MC, Department of Public Health) was invited as a guest speaker to a research seminar at the Imperial Collage in London (UK). Natalie presented her work on the projected number of people with onchocerciasis-loiasis co-infection in Africa, from 1995 to 2025. Onchocerciasis, also known as river blindness, is a disease caused by infection with the nematode worm Onchocerca volvulus. Long-term infection may ultimately lead to blindness. Ivermectin is the drug used at a large-scale in onchocerciasis elimination programmes. However, for individuals that are co-infected with Loa loa, the African eye worm, ivermectin may cause severe adverse events (SAEs), potentially even death. The seminar presented estimations on how many people would be at risk of SAEs and how many people would thus benefit from alternative treatment strategies and drugs for onchocerciasis in L. loa endemic areas.
Natalie Vinkeles Melchers, Wilma Stolk and Luc Coffeng from the Erasmus MC (Department of Public Health) were invited to the World Health Organization (WHO), Department of Neglected Tropical Diseases, to discuss their work on a modeling study on the impact of ivermectin on skin and eye disease due to onchocerciasis with projections up to 2025. Drs. Vinkeles Melchers presented her recent work, and showed an expanded disease framework within the individual-based mathematical ONCHOSIM model. She used the disease module to predict trends in the prevalence of onchocercal eye and skin disease during a 25-year time frame since start of MDA. Predicted prevalence was projected for various clinical manifestations due to onchocerciasis; reversible conditions (itch and reactive skin disease) and irreversible manifestations (skin atrophy, depigmentation, hanging groin, vision loss). The meeting was attended by WHO experts in the field of, among others, onchocerciasis, lymphatic filariasis, Chagas, and was deemed very successful.
On Thursday 11th May, the RGHI held a special session at the Lowlands Health Economics Study Group (lolaHESG) 2017. Four papers were presented on various topics by members of all three research groups (iBMG, Public Health & ISS) such as Universal Health Coverage in Indonesia, Health Insurance in Nigeria, Child Marriages in Bangladesh and Neonatal mortality. There was a lively discussion after each of the presentations, which led to useful feedback for all participants.
Photo: From left-to-right. Chairman: Eddy van Doorslaer. Speakers: Sofia Trommlerova, Igna Bonfrer, Tanja Houweling, Ahmed Fuady.
In August-September 2016, Erasmus MC is hosting a unique series of four Masterclasses by renowned experts in global health from around the world. Global health is one of the target domains of Erasmus MC, which this year is celebrating the 50th Anniversary of its School of Medicine, putting global health ambitions center stage: ‘Bridging Ambitions, Building Excellence’.
Hans Hogerzeil currently is Professor of Global Health at Groningen University (Netherlands). After working as a mission doctor, he joined the WHO Action Programme of Essential Drugs in 1985 and was the Director for Essential Medicines and Pharmaceutical Policies from 2008 to 2011.
Wednesday August 24, 9am-1pm Erasmus MC, Querido Hall Masterclass on ‘Global Health Local: Global Health in Rotterdam’, by Professor Lex Burdorf, Professor Semiha Denktas and Elly van Kooten. https://www.facebook.com/events/325795761094621/
Elly van Kooten is DIrector Public Health Rotterdam. Lex Burdorf is Professor in Determinants of Public Health at Erasmus MC. Semiha Denktas studies environmental, personal, and behavioural characteristics to explain why and how behaviours change, with a focus on vulnerable groups in society.
Ellen Van de Poel, Leander Buisman, Eddy Van Doorslaer and Owen O’Donnell started a UNICEF project on the Analysis of nationally representative surveys to examine the determinants of stunting in selected low- and middle-income countries (90.000 euro)
The Erasmus Center for Health Economics Research (ESCHER) – a collaboration between ESE, iBMG, EMC has been awarded with a Research Excellence Initiative Grant. Among many other activities to boost Health Economics Research in Rotterdam, Arjun Bedi and Eddy Van Doorslaer will co-supervise a PhD student in the field of Global Health.
ISS PhD researcher Runa Laila and Kristen Cheney are involved in a RGHI two-year 490.000-euro WOTRO grant within the Sexual and Reproductive Health Research programme. The project is called “Psychodrama as transformative intervention in the SRH of young men in urban slums in Dhaka; proof of a novel approach.”
iBMG-Health Economics submitted a proposal to the EU’s Horizon 2020 program (6 million euro) on the topic of Translating Evidence on Provider Incentives in Primary Care. Partners are EMC, Wageningen, LSHTM, Karolinska and research institutes in Indonesia, Philippines and Vietnam.
The Zika outbreak and its consequences show how important public information is in prevention and control of infectious diseases.
The WHO declared a global health emergency for Zika in February and announced last week that there is strong scientific consensus that Zika virus can cause GBS, microcephaly and other neurological disorders.
A large group of global health minors students at the Medical Faculty at Erasmus MC recently completed their exchange journeys abroad. They returned enriched and with a lot of enthusiasm. In an article in Scanner, several of them narrate their experiences. See www.facebook.com/minorglobalhealth2015 and this PDF.
This week, in Paris the international climate conference COP21 takes place. In June, the Lancet Commission on Health and Climate Change launched a seminal research report, which underscores that “responding to climate change could be the biggest global health opportunity of the 21st century.” The report provides key policy recommendations for governments to take action in the next five years.
Measuring Impact and Having Impact are not always the same thing. On the occasion of the honorary doctorate awarded this week to prof. Paul Gertler at Erasmus University, a core of topresearchers in the field of impact evaluations in health gathered in the Erasmus Pavillion for a special international conference devoted to innovations in global health financing.
Measuring Impact and Having Impact are not always the same thing. On the occasion of the honorary doctorate to Paul Gertler, one of the world’s best known researchers on impact evaluations in health, RGHI co-organizes a one-day seminar on state-of-the-art questions around evaluating health financing strategies and health impact.
A blog by Adam Wagstaff, the World Bank’s Research Manager of the Human Development and Public Services, Development Research Group features two recent studies by RGHI partner iBMG (Van de Poel, Bonfrer a.o.). Wagstaff reviews the ongoing quest of what works in trying to incentivize quality care.
International Symposium 11 June 2015 This symposium brought together the evidence from recent impact evaluations of African health financing reforms, which aim to bring about Universal Health Coverage (UHC). A full house of participants attended the presentations of selected cases varying from the evaluations of community-based health insurance to performance based financing schemes. A lively debate ensued on identifying more general policy lessons on how to move forward to UHC. The presentations addressed general socio-economic and health developments in Africa by Dr. Agnes Soucat (World Bank), ongoing impact evaluations community-based health insurance schemes in Ethiopia and their policy implications by Prof. Arjun Bedi (International Institute for Social Studies), the evaluation of the insurance program in Kwara state Nigeria by Prof. Jacques van der Gaag (Amsterdam Institute for International Development), an indepth assessment of the Ghana NHIS by Dr. Caroline Jehu-Appiah (African Development Bank) and presentations on PBF by Dr. Igna Bonfrer (iBMG) and Prof. Bruno Meessen (Institute of Tropical Medicine) . The day was chaired by Prof. Eddy van Doorslaer (Erasmus University) and moderated by Dr. Ellen Van de Poel (Erasmus University) & Prof. Owen O’Donnell (Erasmus University). The conference culminated in the afternoon in the successful public defence of her PhD thesis by Igna Bonfrer on the very topic of the day’s meetings: the evaluation of health financing models.
Over 50% of the world’s inhabitants reside in cities. The huge challenges this rapid global urbanization poses to health were addressed at the 12th International Conference for Urban Health (ICUH 2015) in Dhaka, Bangladesh from May 24-27, 2015
The rural health development program in China, Health XI, gathered a major dissemination conference in Beijing on November 19. Over 350 participants attended the meeting and shared some major achievements in the 8 provinces which were partner in Health XI. The project, funded by the World Bank and DFID, has been one of the largest rural health reform projects globally. The lessons learned will feed into future Chinese health developments but also have great relevance outside China. RGHI/ iBMG was present as the independent external evaluators of Health XI. ThIs evaluation will be completed next year.
Today, the short film we made during the October 20 Dutch national ebola debate at Erasmus MC has come on- line. A month after this debate the situation is West Africa with over 15000 cases and over 5000 people dead still requires our urgent attention. RGHI is actively involved in the discussions on the structural reconstruction after the epidemic has been brought under control.
In a fully booked main auditorium of Erasmus Medical Center, the Dutch National Ebola Debate took place on Monday 20 October, with many of the key stakeholders from the ebola science and emergency communities present. In several presentations the current state of affairs was discussed and an urgent call for action was mounted, primarily to support the international efforts in West-Africa with self-managing teams, but also to take stock of the various procedures for prevention and management worldwide. ‘It’s is false to think this is an African story’, virology prof. Eric Van Gorp stressed, ‘this is a global affair which concerns us all. We need to face this scourge together’.”
Nationaal ebola actualiteitencafé op 20 oktober in Rotterdam On October 20, RGHI and Erasmus MC will host the national ebola urgency debate. Time: 12-14h, Location: Erasmus MC, main lecture hall 2 (new education building). Event is organised together with RIVM/VWS, Ministry of Foreign Affairs, Cordaid, MSF, and Netherlands Platform for Global Health Policy and Health Systems Research. Please register firstname.lastname@example.org if you wish to attend.
On September 30, 15-17h, RGHi will co-host the special session ‘Disrupt in Order to Sustain’ during the global health systems research conference in Capetown, South Africa. Together with the Netherlands Platform for Global Health Policy and Health Systems Research we will address the key innovations which are urgently needed to advance global health much more structurally. See also the film we made in May 2013, when we launched this debate
On Sept 3, 2014, WHO lead expert on Universal Health Coverage, Joe Kutzin, engaged in a lively debate organised by the Netherlands Platform and RGHI in Rotterdam. In the presence of health systems researchers, postdocs and health systems reform implementers, Kutzin discussed the progress made in the UHC policy agenda but also tackled a number of pitfalls to avoid. He shared several clear messages with the audience.
On July 3, 2014, Representatives of RGHI and the five business partners of the Rotterdam Alliance for Serious Games and Creative Learning got together to discuss our actions for the coming months. The full agenda will be issued in September.
On the day of the worst storm in Western Europe since the 1980s representatives of the Rotterdam Global Health Initiative and Erasmus MC, ITPreneurs, Lucidious, Organiq, Ranj and Vertigo gathered at the Games for Health Europe conference to launch the Rotterdam Creative Coalitions (RCC) for Serious Games & Innovative Learning in Global Health.
“Disrupt in Order to Sustain”. This appeal best captures the general spirit of the international global health innovators event “Towards Sustainable Global Health Architecture, Facing the Challenges”, held in Rotterdam on May 15, 2013. Over 120 global health researchers, social entrepreneurs, implementers and policy-makers had accepted the invitation of the Netherlands Platform for Global Health Policy and Health Systems Research, and the Rotterdam Global Health Initiative to join in and discuss the future of global health efforts. They actively engaged with a series of provocative sustainability messages of eight international key-note speakers. Their morning presentations were followed by animated round-table conversations in the afternoon, and culminated in a final panel with prof. Suzanne Kiwanuka (Public Health, Makerere University, Uganda) and prof. Jan Rotmans (DRIFT, Erasmus University) who addressed the necessary battles that have to be fought to make the transitions into the new world.